Fig. 4From: Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastomaDistribution of the CDI in CGGA validation cohort. A) Classification of patients into different risk groups based on the CDI. B) distribution of patients’ survival time and status. C) Kaplan–Meier survival analysis suggested that patients’ OS were significantly different between high CDI and low CDI group. D) The prognostic performance of CDI demonstrated by ROC curves for predicting the 1.5-, 3.0-, and 4.5- year OS ratesBack to article page